Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2001

01-10-2001 | Case Report

Second Transplantation With CD34+ Blood Cells From an HLA-Mismatched Related Donor After Engraftment Failure of Transplanted Cord Blood Cells

Authors: Hideaki Ohta, Ji Yoo Kim, Akihisa Sawada, Sadao Tokimasa, Hiroyuki Fujisaki, Yoshiko Matsuda, Yuko Osugi, Junichi Hara

Published in: International Journal of Hematology | Issue 3/2001

Login to get access
Metadata
Title
Second Transplantation With CD34+ Blood Cells From an HLA-Mismatched Related Donor After Engraftment Failure of Transplanted Cord Blood Cells
Authors
Hideaki Ohta
Ji Yoo Kim
Akihisa Sawada
Sadao Tokimasa
Hiroyuki Fujisaki
Yoshiko Matsuda
Yuko Osugi
Junichi Hara
Publication date
01-10-2001
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2001
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02982071

Other articles of this Issue 3/2001

International Journal of Hematology 3/2001 Go to the issue

Rapid Communication

CD7+ Near-Tetraploid Acute Myeloblastic Leukemia M2 With Double t(8;21)(q22;q22) Translocations and AML1/ETO Rearrangements Detected by Fluorescence In Situ Hybridization Analysis

Letter to the Editor

Severe Autoimmune Hemolitic Anemia as a Potentially Fatal Complication of EBV Infectious Mononucleosis

Letter to the Editor

Successful Eradication of Residual bcr-abl-Positive Clones by Donor Leukocyte Transfusion in a Patient With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia After Peripheral Blood Stem Cell Transplantation

Rapid Communication

A Simple Centrifugation Method for Harvesting Myeloblasts

Rapid Communication

A New Anti-Hemoglobin F Antibody Against Synthetic Peptides for the Detection of F-Cell Precursors (F-blasts) in Bone Marrow

OriginalPaper

The Role of the AML1 Transcription Factor in Leukemogenesis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits